v3.26.1
Note 5 - Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2026
Table Text Block [Abstract]  
Schedule of Stockholders' Equity warrant outstanding and exercisable.

The following table summarizes the Company's outstanding and exercisable common stock warrants as of June 30, 2026:

Common Stock Warrants

 

Classification

 

Number of
Warrants Outstanding
and Exercisable

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

 

October 2025 Offering Pre-Funded Common Stock Warrants

 

Equity-classified

 

 

37,814,754

 

 

$

0.0001

 

 

Perpetual

 

(1)

July 2025 Warrant Inducement Replacement Common Stock Warrants

 

Equity-classified

 

 

8,637,810

 

 

 

0.9047

 

 

 

4.43

 

 

February 2024 Warrant Inducement Replacement Common Stock Warrants

 

Equity-classified

 

 

113,804

 

 

 

10.97

 

 

 

2.59

 

 

Series 2 Common Stock Warrants

 

Equity-classified

 

 

6,748

 

 

 

0.70

 

 

 

1.12

 

 

Bridge and January 2022 Common Stock Warrants

 

Liability-classified

 

 

2,612

 

 

 

2,804.69

 

 

 

0.13

 

 

Placement Agent, Solicitor and Representative Common Stock Warrants

 

Equity-classified

 

 

5,084,891

 

 

 

1.70

 

 

 

4.19

 

 

All Other Common Stock Warrants

 

Equity-classified

 

 

775

 

 

 

11,603.25

 

 

 

0.95

 

 

Total Warrants Outstanding and Exercisable, June 30, 2026

 

 

 

 

51,661,394

 

 

 

0.66

 

 

 

4.32

 

(1)

(1) The pre-funded common stock warrants outstanding as of June 30, 2026 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.

Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes all common stock warrant activity during the six months ended June 30, 2026:

 

 

Number of
Warrants

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

 

Warrants outstanding, December 31, 2025

 

 

64,031,148

 

 

$

0.53

 

 

 

4.81

 

(1)

Granted

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(12,369,753

)

 

 

0.0126

 

 

 

 

 

Forfeited, expired or cancelled

 

 

(1

)

 

 

20,692.50

 

 

 

 

 

Warrants outstanding, June 30, 2026

 

 

51,661,394

 

 

 

0.66

 

 

 

4.32

 

(1)

(1) The pre-funded common stock warrants outstanding as of June 30, 2026 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.